ACAD
ACADIA PHARMACEUTICALS INC
+0.02 (+0.07%)27.56USD465K成交股數4.7B市值12.4本益比(近四季)4.2股價營收比+16.4%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 308M+16% | 268M+10% | 284M+13% | 279M+15% | 265M+29% | 244M+6% | 250M+18% | 242M+46% | 206M | 231M | 212M | 165M |
| 營業成本 | 28.3M | 24.8M | 26.2M | 21.6M | 20.7M | 20.4M | 18.9M | 18.2M | 23.0M | – | 14.6M | 7.5M |
| 毛利 | 280M+15% | 243M+9% | 258M+11% | 257M+15% | 244M+33% | 224M+5% | 232M+17% | 224M+42% | 183M | 213M | 197M | 158M |
| 毛利率 | 90.8% | 90.8% | 90.8% | 92.2% | 92.2% | 91.7% | 92.5% | 92.5% | 88.8% | 92.3% | 93.1% | 95.5% |
| 研發費用 | 81.6M | 76.9M | 84.8M | 87.8M | 78.0M | 78.3M | 66.6M | 76.2M | 59.7M | – | 157M | 58.8M |
| 銷售管理費用 | 160M | 171M | 156M | 133M | 134M | 126M | 133M | 117M | 108M | – | 97.9M | 96.0M |
| 營業利益 | 37.8M+17% | −4.6M-124% | 17.4M-45% | 35.8M+17% | 32.4M+113% | 19.3M | 31.6M-155% | 30.4M+902% | 15.2M | – | −57.8M | 3.0M |
| 營業利益率 | 12.3% | -1.7% | 6.1% | 12.8% | 12.2% | 7.9% | 12.6% | 12.6% | 7.4% | – | -27.3% | 1.8% |
| 稅後淨利 | 31.5M+18% | 3.6M-81% | 274M+735% | 71.8M+115% | 26.7M+61% | 19.0M-59% | 32.8M-150% | 33.4M+2897% | 16.6M | 45.8M | −65.2M | 1.1M |
| 淨利率 | 10.2% | 1.4% | 96.3% | 25.8% | 10.1% | 7.8% | 13.1% | 13.8% | 8.0% | 19.8% | -30.8% | 0.7% |
| 稀釋 EPS | 0.18+13% | 0.02-82% | 1.61+705% | 0.42+110% | 0.16+60% | 0.11-61% | 0.20-150% | 0.20+1900% | 0.10 | 0.28 | -0.40 | 0.01 |
| 稀釋股數 | 173M | 173M | 170M | 171M | 169M | 168M | 166M | 166M | 167M | – | 164M | 165M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 385M | 282M | 178M | 258M | 254M | 218M | 155M | 177M | 205M | 189M | 98.2M | 108M |
| 應收帳款 | 151M | 135M | 121M | 116M | 108M | 106M | 98.2M | 104M | 94.7M | 98.3M | 92.8M | 81.9M |
| 存貨 | 109M | 112M | 111M | 106M | 111M | 103M | 86.7M | 86.1M | 66.6M | 40.4M | 25.4M | 14.1M |
| 總資產 | 1.7B | 1.6B | 1.6B | 1.3B | 1.2B | 1.1B | 977M | 914M | 855M | 749M | 633M | 643M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 436M | 357M | 337M | 413M | 403M | 367M | 400M | 397M | 391M | 317M | 270M | 247M |
| 股東權益 | 1.3B | 1.2B | 1.2B | 917M | 822M | 765M | 577M | 517M | 464M | 432M | 362M | 396M |
| 負債比 | 25.0% | 22.3% | 21.5% | 31.1% | 32.9% | 32.4% | 40.9% | 43.5% | 45.7% | 42.4% | 42.7% | 38.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 34.0M+67% | – | – | – | 20.3M | – | – | 29.1M | – | – | – |
| 資本支出 | – | 5.2M | – | – | – | 0.00 | – | – | – | – | – | – |
| 自由現金流 | – | 28.8M+42% | – | – | – | 20.3M | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 10.7% | – | – | – | 8.3% | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 1.1B
| Reportable Segment Aggregation Before Other Operating | 1.1B | 100.0% | +11.9% |
|---|
主要客戶2025 年度 · 1.1B
| Nuplazid | 680M | 63.5% | +11.6% |
|---|---|---|---|
| Daybue | 391M | 36.5% | +12.3% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.1B | +11.9% | 391M | 36.5% | 2.30 | 105M |
| FY2024 | 958M | +31.8% | 226M | 23.6% | 1.36 | 157M |
| FY2023 | 726M | +40.4% | −61.0M | -8.4% | -0.37 | 16.7M |
| FY2022 | 517M | +6.8% | −214M | -41.4% | -1.34 | −114M |
| FY2021 | 484M | +9.6% | −168M | -34.7% | -1.05 | −127M |
| FY2020 | 442M | +30.3% | −282M | -63.7% | -1.79 | −144M |
| FY2019 | 339M | +51.5% | −235M | -69.4% | -1.60 | −152M |
| FY2018 | 224M | – | −245M | -109.6% | -1.94 | −170M |